ACINETOBACTER BAUMANNII-CALCOACETICUS COMPLEX

Clinical trials for ACINETOBACTER BAUMANNII-CALCOACETICUS COMPLEX explained in plain language.

Never miss a new study

Get alerted when new ACINETOBACTER BAUMANNII-CALCOACETICUS COMPLEX trials appear

Sign up with your email to follow new studies for ACINETOBACTER BAUMANNII-CALCOACETICUS COMPLEX, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Race against superbug: new drug combo enters final testing for deadly hospital pneumonia

Disease control Not yet recruiting

This study is testing a new antibiotic combination (BV100 plus polymyxin B) against a standard treatment for a severe type of pneumonia caught in hospitals. It focuses on infections caused by a bacteria that resists most antibiotics, making them very hard to treat. The main goal …

Matched conditions: ACINETOBACTER BAUMANNII-CALCOACETICUS COMPLEX

Phase: PHASE3 • Sponsor: BioVersys SAS • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

ACINETOBACTER BAUMANNII-CALCOACETICUS COMPLEX

Get alerted when new ACINETOBACTER BAUMANNII-CALCOACETICUS COMPLEX trials appear

Race against superbug: new drug combo enters final testing for deadly hospital pneumonia